News - Biliary and hepatic disorders
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 





DateSubject
05/02/2012 11:11:47 AM
Hepatitis C Drug Can Cause Depression
04/26/2012 02:59:36 PM
FDA: Co-Administration of Boceprevir With Certain Boosted HIV Protease Inhibitors Not Recommended
04/25/2012 04:23:08 PM
Reduction of Tacrolimus Possible With Early Introduction of Everolimus After Liver Transplant: Presented at EASL
04/25/2012 03:51:47 PM
Interferon-Free Combination Regimen Shows Promise for the Treatment of Chronic HCV: Presented at EASL
04/25/2012 03:22:59 PM
Non-Interferon-Based Combination Therapy Offers High Response Rates for Hepatitis C Patients: Presented at EASL
04/25/2012 12:53:01 PM
Short-Term Aramchol Reduces Liver Fat Content Safely in Patients With NAFLD and NASH: Presented at EASL
04/25/2012 11:58:10 AM
Boceprevir Improves Rates of Sustained Virological Response in HCV/HIV Coinfected Patients: Presented at EASL
04/25/2012 11:55:25 AM
Novel Uridine Nucleotide Analogue Safe, Effective for Patients With HCV Receiving Pegylated Interferon/Ribavirin: Presented at EASL
04/25/2012 11:09:01 AM
Eltrombopag Increases Platelet Counts During HCV Treatment in Patients With Thrombocytopenia: Presented at EASL
04/25/2012 11:06:24 AM
Delaying Treatment in New Cases of Hepatitis C Infection Considered Unnecessary: Presented at EASL
04/24/2012 06:15:50 PM
Daclatasvir Plus PSI-7977 Provides Significant Response in Treatment of HCV Across Genotypes: Presented at EASL
04/24/2012 06:06:04 PM
Brivanib Improves Time-to-Progression in Patients With HCC, but Fails to Improve Overall Survival: Presented at EASL
04/24/2012 03:02:56 PM
Family History of Liver Cancer Increases Risk of Developing Hepatocellular Carcinomas
04/24/2012 03:00:27 PM
Boceprevir Helps Prior Nonresponders With HCV Genotype 1 to Achieve SVR: Presented at EASL
04/24/2012 02:57:47 PM
TMC435 Combined With PEG IFN alfa-2a/RBV Is Well Tolerated and Significantly More Effective Than PEG IFN alfa-2a/RBV Alone in HCV Genotype 1: Presented at EASL
04/24/2012 02:53:14 PM
Fibrosis and Fatty Liver Disease Increase Risk of Early Atherosclerosis
04/24/2012 01:22:33 PM
Alisporivir in Hepatitis C Genotype 1 Warrants Further Study, but Research on Hold: Presented at EASL
04/24/2012 12:42:15 PM
PEG IFN Lambda-1a Provides Improved Efficacy and Safety Over IFN Alpha for Treating Hepatitis C: Presented at EASL
04/23/2012 12:31:54 PM
Ultrasound May Not Be Adequate for Liver Cancer Screening in Patients Coinfected With HIV, Hepatitis: Presented at BHIVA
04/19/2012 12:13:54 PM
New Clinical Practice Guideline on Alcoholic Liver Disease Published
04/03/2012 03:52:35 PM
New Biomarker to Identify Patients With HBV At-Risk for Liver Cancer
04/03/2012 01:33:28 PM
Anidulafungin Shows Efficacy in Liver Disease-Related Fungal Infections: Presented at ECCMID
03/23/2012 12:04:17 PM
Study Identifies Genetic Variants Linked to Fatty Liver Disease in Obese Children
03/15/2012 03:22:50 PM
EASL and EORTC Publish Joint Guidelines on Hepatocellular Carcinoma Management
03/08/2012 12:01:23 PM
Boceprevir Added to PEG-IFN Plus Ribavirin Effective for Treating HIV Patients Coinfected With Hepatitis C Virus: Presented at CROI
03/08/2012 11:58:41 AM
Telaprevir Combined With PEG-IFN alfa-2a Plus Ribavirin Benefits Patients Coinfected With Hepatitis C and HIV: Presented at CROI
03/06/2012 12:53:11 PM
Bevacizumab May Be a Therapeutic Option for Hereditary Haemorrhagic Telangiectasia
03/05/2012 03:00:34 PM
Gadoxetic Acid-Enhanced MRI Yields Superior Results in Assessing Patients With Suspected Liver Metastases: Presented at ECR
03/01/2012 03:46:18 PM
FDA Issues Recommendations Concerning Drug-Drug Interactions Between PIs, Statins
03/01/2012 12:35:18 PM
Cyclosporine Induces Higher Sustained Viral Response Rates After Liver Transplant for HCV: Presented at CDDW
02/29/2012 12:51:48 PM
Transient Elastography Accurate for Detecting Sever Fibrosis Due to Recurrent HCV
02/09/2012 11:55:13 AM
Concomitant Use of Boceprevir, Ritonavir-Boosted PIs Can Decrease Efficacy of Both Drugs
02/07/2012 03:52:22 PM
EASL Publishes First European Clinical Practice Guidelines for Wilson’s Disease
02/07/2012 03:37:28 PM
Patients With Cirrhosis, Low Muscle Mass Have a Higher Death Rate
02/06/2012 06:25:31 PM
Three Targeted Cancer Drugs Raise Risk of Fatal Side Effects
02/02/2012 03:19:28 PM
Rituximab Shows Promise for Patients With Primary Biliary Cirrhosis
02/01/2012 04:29:22 PM
Many Paediatric Liver Transplant Recipients Can Safely Stop Immunosuppressive Therapy
02/01/2012 02:54:01 PM
2012 Adult Immunization Schedule Broadens Recommendations for HPV, HBV Vaccinations
02/01/2012 02:49:07 PM
Type of Anaesthesia May Affect Recurrence Risk After Liver Cancer Procedure
01/31/2012 04:29:41 PM
Cardiopulmonary Exercise Testing May Predict Survival After Liver Transplantation
01/26/2012 03:22:11 PM
Live Liver Donation Safer Than Previously Thought
01/19/2012 12:05:36 PM
Combination of Oral Antiviral Agents Can Help Suppress Hepatitis C Virus
01/18/2012 04:20:45 PM
Novel Gene Mutations Associated With Bile Duct Cancer
01/17/2012 03:15:56 PM
Immunosuppression Withdrawal May Be Feasible for Paediatric Liver Transplant Recipients
01/10/2012 12:34:05 PM
New Fibrosis Classification Improves Accuracy of Diagnosis in Hepatitis C
01/10/2012 12:20:08 PM
High Rates of Disability Observed Among Older Patients With Cirrhosis
01/04/2012 03:06:48 PM
Maternal Liver Grafts More Tolerable for Children With Biliary Atresia
12/16/2011 01:19:40 PM
Deferasirox Reduces Iron Overload in Beta-Thalassaemia Patients not Requiring Transfusions: Presented at ASH
12/14/2011 04:28:27 PM
Obesity and Diabetes Epidemics Spur Increase in Nonalcoholic Steatohepatitis
12/02/2011 06:40:27 PM
CT and MRI Similar in Detecting Liver Cancer Among Patients With Cirrhosis: Presented at RSNA
12/02/2011 04:17:16 PM
Ultrasound Surveillance of Liver Cancer Appears to Find Most Lesions at Early Stages: Presented at RSNA
12/02/2011 09:38:57 AM
Adherence to Liver Cancer Screening Guidelines for Patients With HCV Appears Low: Presented at RSNA
12/01/2011 04:11:49 PM
Studies of Patients With Cirrhosis Uncover Limitations in Liver Cancer Screening
12/01/2011 12:24:43 PM
Dual-Energy CT With Spectral Imaging Differentiates Neoplastic From Bland Portal Vein Thrombi: Presented at RSNA
11/25/2011 02:41:51 PM
Researchers Surprised to Find Fatty Liver Disease Poses No Excess Risk for Death
11/11/2011 06:56:14 PM
Replacing Calcineurin Inhibitor With Everolimus Safe With Better Renal Function: Presented at AASLD
11/11/2011 06:42:11 PM
Superiority of Terlipressin Plus Albumin for Hepatorenal Syndrome: Presented at AASLD
11/11/2011 04:23:58 PM
No Hepatitis B Virus Resistance to Tenofovir Seen Out to 5 Years: Presented at AASLD
11/11/2011 11:55:26 AM
Poxvirus Shows Promising Activity Against Hepatocellular Carcinoma: Presented at AASLD
11/11/2011 11:48:39 AM
Eltrombopag Adjunct Therapy Improves HCV Response in Cirrhotic Patients: Presented at AASLD
11/09/2011 04:59:22 PM
Miravirsen Shows Promise Against HCV in First Clinical Trial: Presented at AASLD
11/09/2011 04:55:25 PM
Radiofrequency Ablation, Surgical Resection Equally Effective for Early-Stage Hepatocellular Carcinoma: Presented at AASLD
11/09/2011 04:30:08 PM
Antenatal Lamivudine May Be Deferred to Third Trimester for High-Risk Mothers With HBV: Presented at AASLD
11/09/2011 03:18:40 PM
Telaprevir Improves Treatment of Patients Coinfected With HIV and Hepatitis C Receiving Efavirenz: Presented at AASLD
11/08/2011 04:25:51 PM
Once-Daily Agent Offers 100% SVR Rates Against HCV Genotype 2 or 3: Presented at AASLD
11/08/2011 04:17:17 PM
Danoprevir Helps Treatment-Naïve Patients With HCV Achieve Sustained Virologic Response: Presented at AASLD
11/08/2011 03:45:35 PM
Alisporivir Offers Early Viral Clearance in Half of Patients With Hepatitis C Virus Genotype 2 or 3: Presented at AASLD
11/08/2011 02:45:25 PM
Treatment-Naïve Patients With HCV Achieve Rapid Virological Response With Novel PI, Standard Care: Presented at AASLD
11/08/2011 12:29:35 PM
Telaprevir Improves Response Rates in Patients With Hepatitis C Virus Genotype 1 and Cirrhosis: Presented at AASLD
11/08/2011 12:24:02 PM
Enoxaparin Prevents Portal-Vein Thrombosis, Reduces Decompensation in Advanced Cirrhosis: Presented at AASLD
11/07/2011 05:28:35 PM
Investigational Protease Inhibitor Boosts Sustained Virologic Response in Patients With Hepatitis C Virus Genotype 1: Presented at AASLD
11/07/2011 01:11:43 PM
Black Patients With Hepatitis C Increase Their Sustained Response With Boceprevir: Presented at AASLD
11/07/2011 12:43:38 PM
Utility and Safety for Prolonged Treatment of Chronic Hepatitis B in Children: Presented at AASLD
11/01/2011 03:54:50 PM
Recipients of Organ Transplants at Increased Risk for Broad Range of Cancers
10/26/2011 11:45:26 AM
R0 Resection Remains Goal in Colorectal Liver Metastases: Presented at ACS
10/18/2011 03:28:34 PM
New Strategy Facilitates HCV Screening Among HIV-Positive Individuals
10/17/2011 04:57:52 PM
Largest Ever Genetic Study of Liver Function Could Point the Way to New Treatments
10/05/2011 03:35:22 PM
Excess BMI in Childhood Associated With an Increased Risk of Liver Cancer in Adulthood
09/27/2011 03:51:20 PM
Living Donor Liver Transplantation Improves Survival Over Deceased Donor Transplants
09/27/2011 02:50:35 PM
Regorafenib Safe for Patients With Hepatocellular Cancer Who Have Progressed on Sorafenib: Presented at ECCO-ESMO
09/22/2011 12:30:17 PM
European Medicines Agency Recommends Restricting Use of Dronedarone
09/20/2011 11:56:07 AM
Telaprevir Approved in Europe for Genotype-1 Chronic Hepatitis C Virus
09/15/2011 12:24:09 PM
Shorter Course of Hepatitis C Treatment as Effective as 48-Week Regimen
09/13/2011 05:40:26 PM
Substituting Brand Name Tacrolimus With Generic Form is Safe for Transplant Recipients
09/09/2011 04:33:39 PM
Day 7 Bilirubin Levels Predict Early Graft Survival in Paediatric Liver Transplant Recipients: Presented at ESOT
09/09/2011 03:46:40 PM
Major Postoperative Liver Transplant Complications Associated With Hepatitis Reinfection: Presented at ESOT
09/09/2011 03:39:04 PM
Xerostomia, Burning Mouth Syndrome Common Among Liver Transplant Recipients: Presented at ESOT
08/22/2011 01:26:15 PM
Radioembolisation Improves Chance of Survival for Patients With Liver Cancer
08/22/2011 11:38:04 AM
Health Canada Approves Telaprevir for Patients With Hepatitis C
08/09/2011 04:33:42 PM
New Non-Invasive Technology Shows Promise for Hepatocellular Carcinoma
08/03/2011 11:39:00 AM
Health Canada Approves Boceprevir for the Treatment of Chronic HCV
07/27/2011 05:25:04 PM
Study: Viral Hepatitis Rates Forecast a Liver Health Crisis
07/26/2011 02:42:29 PM
Single-Dose H1N1 Vaccine Not Reliable Protection for Paediatric Liver-Transplant Patients
07/21/2011 04:22:07 PM
Metabolic Syndrome Increases Risk of Primary Liver Cancers
07/21/2011 03:59:58 PM
Hepatitis C Virus is Transmitted by Unprotected Sex Between HIV+ Men
07/21/2011 03:57:53 PM
Study Suggests Obesity Accelerates Progression of Cirrhosis
07/18/2011 01:26:51 PM
European Commission Approves Boceprevir for Chronic Hepatitis C
06/28/2011 03:37:55 PM
Gene Variant Increases Fatty Liver Risk, Fibrosis Progression
06/27/2011 02:56:24 PM
Stepped-Up Vaccine Series for Hepatitis B Effective During Pregnancy
06/23/2011 05:52:55 PM
Telaprevir-Based Regimen Improves HCV Cure Rates
06/22/2011 05:31:01 PM

[Next Page]